Etravirine Tablets ( DrugBank: Etravirine )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
18 | 脊髄小脳変性症(多系統萎縮症を除く。) | 1 |
18. 脊髄小脳変性症(多系統萎縮症を除く。)
臨床試験数 : 76 / 薬物数 : 98 - (DrugBank : 31) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 65
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04273165 (ClinicalTrials.gov) | September 17, 2020 | 14/2/2020 | Safety and Efficacy of Etravirine in Friedreich Ataxia Patients | A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia Patients | Friedreich Ataxia | Drug: Etravirine Tablets | IRCCS Eugenio Medea | University of Rome Tor Vergata | Active, not recruiting | 10 Years | 40 Years | All | 30 | Phase 2 | Italy |